TABLE 3

Lung volume measurements

	Baseline	0 h post-LVR	1 h post-LVR	2 h post-LVR
RMW
TLC L	2.72±0.48*	2.89±0.52*	3.09±0.56*	2.96±0.53*
VC L	1.17±0.23*	1.21±0.23*	1.23±0.25*	1.17±0.22*
IC L	0.96±0.21*	0.98±021*	1.01±0.23*	0.99±0.21*
FRC L	1.77±0.29*	1.91±0.32*	2.08±0.35*	1.97±0.33*
ERV L	0.22±0.06*	0.24±0.06*	0.23±0.06*	0.19±0.06*
RV L	1.55±0.27	1.68±0.30	1.86±0.33	1.77±0.32
PEF L·s⁻¹	2.67±0.38*	2.64±0.35*	2.57±0.35*	2.67±0.37*
PCF L·s⁻¹	2.49±0.39*	2.36±0.31*	2.53±0.34*	2.52±0.35*
Controls
TLC L	6.77±0.24	6.87±0.28	6.82±0.27	6.86±0.29
VC L	5.24±0.18	5.30±0.20	5.38±0.21	5.33±0.21
IC L	3.43±0.17	3.44±0.17	3.54±0.21	3.51±0.19
FRC L	3.30±0.19	3.40±0.20	3.25±0.21	3.31±0.21
ERV L	1.78±0.10	1.83±0.09	1.80±0.14	1.78±0.11
RV L	1.52±0.12	1.57±0.12	1.44±0.09	1.53±0.12
PEF L·s⁻¹	10.20±0.56	10.25±0.64	10.01±0.48	10.23±0.61
PCF L·s⁻¹	10.07±0.50	10.05±0.63	10.38±0.67	10.35±0.65

Data are presented as mean±sem. LVR: lung volume recruitment; RMW: respiratory muscle weakness; TLC: total lung capacity; VC: vital capacity; IC: inspiratory capacity; FRC: functional residual capacity; ERV: expiratory reserve volume; RV: residual volume; PEF: peak expiratory flow; PCF: peak cough flow. *: p<0.05 for RMW versus control subjects.